Metabolites-Based Network Pharmacology to Preliminarily Verify In Vitro Anti-Inflammatory Effect of Ardisiacrispin B
Wen Zhou, Guixiang Yang, Yushuang Wen, Qian Xiao, Le Sun, Yongjun Li, Zipeng Gong, Yonglin Wang · 2023
Read Metabolites-Based Network Pharmacology to Preliminarily Verify In Vitro Anti-Inflammatory Effect of Ardisiacrispin B by Wen Zhou, Guixiang Yang, Yushuang Wen, Qian Xiao, Le Sun, Yongjun Li, Zipeng Gong, Yonglin Wang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10707123.txt.
Description
Wen Zhou and co-authors test whether a plant saponin, and the forms it takes after the body processes it, can calm inflammation. Their 2023 study starts from a traditional herb whose root is prized for anti-inflammatory effect. The compound, ardisiacrispin B, makes up over sixteen percent of the extract, yet its fame so far was anti-tumor, and as a large molecule it likely acts partly through metabolites.
Network pharmacology first predicted the targets of the parent compound and its breakdown products. Cell tests then checked the predictions in vitro. Including metabolites matters: judging only the swallowed form can miss the agents that actually do the work.
Catalog record
| CREATOR | Wen Zhou, Guixiang Yang, Yushuang Wen, Qian Xiao, Le Sun, Yongjun Li, Zipeng Gong, Yonglin Wang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |